Added to YB: 2026-08-10
Pitch date: 2026-08-06
SEER [neutral]
Seer, Inc.
-0.91%
current return
Author Info
Value Never Sleeps shares value investment ideas in micro cap stocks. Sign up for the newsletter.
Company Info
Seer, Inc., a life sciences company, develops and commercializes products to decode the biology of the proteome to improve human health in the United States, China, Australia, Europe, Israel, Japan, and South Africa.
Market Cap
$120.4M
Pitch Price
$2.19
Price Target
N/A
Dividend
N/A
EV/EBITDA
0.33
P/E
-1.76
EV/Sales
-1.53
Sector
Life Sciences Tools and Services
Category
special_situation
An Update on the Seer Situation
SEER (update): Trades $2.20 vs ~$3.70/sh net cash (59c on dollar). Activist Radoff-JEC lost board vote but 3 directors got 43-56% withheld; poison pill ratification failed, expires Feb 2027. Competing bids: Radoff $2.55+85% CVR (6-12mo) vs CEO Farokhzad $2.45+capped non-tradeable CVR to 2033. Now a governance/deal bet, not clean bargain. Risk: no deal, melting cash. Q2 Aug 11.
Read full article (4 min)